Merck & Co., Inc. (MRK) vs The Procter & Gamble Company (PG)

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.

Founded in 1837, Procter & Gamble Company (PG) has grown into one of the world’s largest consumer goods manufacturers, generating nearly $85 billion in annual sales. Its portfolio includes many leading brands, with more than 20 producing over $1 billion in global annual revenue each, including Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. International markets account for slightly more than half of the company’s consolidated sales.